QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: mol.104.008276v1 67/4/1111    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Barbouche, R. Articles by Fenouillet, E. Search for Related Content PubMed PubMed Citation Articles by Barbouche, R. Articles by Fenouillet, E.

Original Article

Glycosaminoglycans and Protein Disulfide Isomerase-Mediated Reduction of HIV Env

Centre National de la Recherche Scientifique, Faculte de Medecine Nord, Marseille, France (R.B., E.F.); Institut de Biologie Structurale, Grenoble, France (H.L.J.); and School of Animal and Microbial Sciences, University of Reading, Reading, England, United Kingdom (I.M.J.)

Abstract

Conformational changes within the human immunodeficiency virus-1 (HIV-1) surface glycoprotein gp120 result from binding to the lymphocyte surface receptors and trigger gp41-mediated virus/cell membrane fusion. The triggering of fusion requires cleavage of two of the nine disulfide bonds of gp120 by a cell-surface protein disulfide-isomerase (PDI). Soluble glycosaminoglycans such as heparin and heparan sulfate bind gp120 via V3 and, possibly, a CD4-induced domain. They exert anti-HIV activity by interfering with the HIV envelope glycoprotein (Env)/cell-surface interaction. Env also binds cell-surface glycosaminoglycans. Here, using surface plasmon resonance, we observed an inverse relationship between heparin binding by gp120 and its thiol content. In vitro, and in conditions in which gp120 could bind CD4, heparin and heparan sulfate reduced PDI-mediated gp120 reduction by approximately 80%. Interaction of Env with the surface of lymphocytes treated using sodium chlorate, an inhibitor of glycosaminoglycan synthesis, led to gp120 reduction. We conclude that besides their capacity to block Env/cell interaction, soluble glycosaminoglycans can effect anti-HIV activity via interference with PDI-mediated gp120 reduction. In contrast, their presence at the cell surface is dispensable for Env reduction during the course of interaction with the lymphocyte surface. This work suggests that the reduction of exofacial proteins in various diseases can be inhibited by compounds targeting the substrates (not by targeting PDI, as is usually done), and that glycosaminoglycans that primarily protect proteins by preserving them from proteolysis also have a role in preventing reduction.

Address correspondence to: Dr. Emmanuel Fenouillet, Centre National de la Recherche Scientifique, Faculte de Medecine Nord, Bd Pierre Dramard, F-13015 Marseille, France. E-mail: fenouillet.e{at}jean-roche.univ-mrs.fr

This article has been cited by other articles:

				E. Crublet, J.-P. Andrieu, R. R. Vives, and H. Lortat-Jacob The HIV-1 Envelope Glycoprotein gp120 Features Four Heparan Sulfate Binding Domains, Including the Co-receptor Binding Site J. Biol. Chem., May 30, 2008; 283(22): 15193 - 15200. [Abstract] [Full Text] [PDF]

				J. Billington, T. P. Hickling, G. H. Munro, C. Halai, R. Chung, G. G. Dodson, and R. S. Daniels Stability of a Receptor-Binding Active Human Immunodeficiency Virus Type 1 Recombinant gp140 Trimer Conferred by Intermonomer Disulfide Bonding of the V3 Loop: Differential Effects of Protein Disulfide Isomerase on CD4 and Coreceptor Binding J. Virol., May 1, 2007; 81(9): 4604 - 4614. [Abstract] [Full Text] [PDF]

				D. Lavillette, R. Barbouche, Y. Yao, B. Boson, F.-L. Cosset, I. M. Jones, and E. Fenouillet Significant Redox Insensitivity of the Functions of the SARS-CoV Spike Glycoprotein: COMPARISON WITH HIV ENVELOPE J. Biol. Chem., April 7, 2006; 281(14): 9200 - 9204. [Abstract] [Full Text] [PDF]